Nucleate Announces Three-Year Partnership with MilliporeSigma to Support Early-Stage Biotech Companies

Nucleate, a nonprofit organization dedicated to empowering future biotech leaders, is excited to announce that MilliporeSigma will renew its sponsorship with a three-year commitment. This partnership will significantly bolster support for early-stage biotech companies emerging from Nucleate’s Activator program.

Over the past five years, Nucleate’s equity-free Activator program has supported 411 teams, helping them raise over $387 million and create more than 233 jobs. This renewed collaboration with MilliporeSigma ensures continued access to state-of-the-art molecular tools and scientific expertise, essential for advancing life-saving therapies, diagnostics, and preventative solutions.

“MilliporeSigma’s renewed commitment underscores the value they see in supporting the next generation of biotech innovators,” said Isabella, Nucleate Leader. “Together, we aim to provide early-stage scientists and academics with the resources they need to transform groundbreaking ideas into impactful solutions.”

MilliporeSigma’s network of scientific experts will offer invaluable insights and mentorship to Nucleate ventures, fostering an environment of innovation and growth. Additionally, the partnership will highlight non-traditional careers in science, showcasing diverse pathways for aspiring biotech professionals.

“Collaborating with Nucleate aligns perfectly with our purpose to impact life and health with science,” said Stephanie Grandbois, MilliporeSigma Representative. “We are proud to support the brilliant minds in Nucleate’s Activator program and look forward to seeing the incredible advancements they will achieve.”

The partnership kicked off with an exciting event earlier this month, where MilliporeSigma welcomed Nucleate leaders and ventures for a day of learning and networking. Highlights included a roundtable discussion, tours of the innovation and training labs, in house recording studio, and a panel on AI in Drug Discovery.

This three-year sponsorship embodies the shared commitment of MilliporeSigma and Nucleate to advance biotechnology and foster innovation within the global scientific community.

About Nucleate

Nucleate is a nonprofit organization dedicated to empowering the next generation of biotech leaders. With chapters spanning 38 geographic regions and participation from over 280 academic institutions, Nucleate sparks new intellectual communities and embeds emerging talent within a global biotech community. Through open-access educational programming, Nucleate helps democratize biotech innovation — removing barriers and helping founders concentrate on building transformational technologies.

Visit www.nucleate.org for more information, and email contact@nucleate.org if you want to get involved with our programming.